12:00 AM
Dec 04, 2014
 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information
Breast cancer Inhibitor of k-light polypeptide gene enhancer in B cells kinase-e (IKBKE; IKKe); Janus kinase (JAK) In vitro and mouse studies suggest inhibiting IKBKE could...

Read the full 264 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD